NT-proBNP

Advertisement
Mark Belkin, MDACC 2021 Conference | April 17, 2025
Editor's Note: This dispatch from ACC.21 was written by Mark Belkin, MD, a cardiology fellow at the University of ...
Read More
DocWire News EditorsAHA Scientific Sessions 2018 | April 17, 2025
Empagliflozin, an SGLT2 inhibitor, significantly reversed left ventricular (LV) remodeling in a population of diabetic ...
DocWire News EditorsAtrial Fibrillation | April 17, 2025
Biomarkers were useful in predicting specific causes of death in patients with atrial fibrillation ...
DocWire News EditorsACC 2018 Conference | April 17, 2025
The beta-blocker carvedilol showed some benefit for protecting against heart injury resulting from chemotherapy-induced ...
Advertisement
Advertisement